Clearmind Medicine Inc. (NASDAQ:CMND – Get Free Report) shares were up 6.3% during trading on Friday . The stock traded as high as $1.60 and last traded at $1.53. Approximately 208,423 shares were traded during trading, a decline of 54% from the average daily volume of 450,170 shares. The stock had previously closed at $1.44.
Clearmind Medicine Stock Up 6.3 %
The firm’s fifty day simple moving average is $1.40 and its 200 day simple moving average is $1.41. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 0.01.
About Clearmind Medicine
Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.
Featured Stories
- Five stocks we like better than Clearmind Medicine
- EV Stocks and How to Profit from Them
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- About the Markup Calculator
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- Why Invest in 5G? How to Invest in 5G Stocks
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Clearmind Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clearmind Medicine and related companies with MarketBeat.com's FREE daily email newsletter.
